Characterisation of artemisinin–chloroquinoline hybrids for potential metabolic liabilities

Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinin–triazine hybrids and hybrid-dimers

(2014) Theunis T. Cloete et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and in vitro biological evaluation of aminoacridines and artemisinin–acridine hybrids

(2014) Juan P. Joubert et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Design, Synthesis, and Antiplasmodial Activity of Hybrid Compounds Based on (2R,3S)-N-Benzoyl-3-phenylisoserine

(2013) Peter M. Njogu et al.   ACS Medicinal Chemistry Letters

Assessment of the Molecular Marker of Plasmodium falciparum Chloroquine Resistance (Pfcrt) in Senegal after Several Years of Chloroquine Withdrawal

(2012) Magatte Ndiaye et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Design and Evaluation of Primaquine-Artemisinin Hybrids as a Multistage Antimalarial Strategy

(2011) Rita Capela et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of highly active novel artemisinin–chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum

(2011) Tzu-Shean Feng et al.   BIOCHEMICAL PHARMACOLOGY

Return of Chloroquine‐Susceptible Falciparum Malaria in Malawi Was a Reexpansion of Diverse Susceptible Parasites

(2010) Miriam K. Laufer et al.   JOURNAL OF INFECTIOUS DISEASES

Hybrid Drugs for Malaria

(2009) J. Walsh et al.   CURRENT PHARMACEUTICAL DESIGN

In Vitro and in Silico Identification and Characterization of Thiabendazole as a Mechanism-Based Inhibitor of CYP1A2 and Simulation of Possible Pharmacokinetic Drug-Drug Interactions

(2009) R. S. Thelingwani et al.   DRUG METABOLISM AND DISPOSITION

Artemisinin Resistance inPlasmodium falciparumMalaria

(2009) Arjen M. Dondorp et al.   NEW ENGLAND JOURNAL OF MEDICINE